Statistics for Pyxis Oncology, (id:8320 PYXS)
Valuation metrics
Market cap
274.53M
Enterprise value
137.46M
Trailing P/E (ttm)
-1.03
Forward P/E
-3.88
PEG ratio
-3.88
Price/Sales (ttm)
17.00
Price/Book (mrq)
1.64
Enterprise Value/Revenue
8.51
Enterprise Value/EBITDA
-2.18
Overview
Shares outstanding
59.42M
Float
38.74M
Shares short
4.91M
% Held by insiders
0.25%
% Held by institutions
0.56%
Average volume (10 days)
622.57K
Average volume (90 days)
Price summary
52-Week low
1.48
52-Week high
6.85
52-Week change
18.42%
Beta
1.28
50-Day moving average
3.62
200-Day moving average
4.05
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
-409.25%
Operational effectiveness
Return on assets
-21.53%
Return on equity
-37.58%
Income statement
Revenue (ttm)
0.33
Revenue per share (ttm)
0.33
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-63,163,000.00
Net income to common (ttm)
-59,203,000.00
Diluted EPS (ttm)
-1.27
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
155.72M
Total cash per share (mrq)
2.64
Total debt (mrq)
20.87M
Total Debt/Equity (mrq)
12.29
Current ratio (mrq)
953.10%
Book value per share (mrq)
2.81
Cash flow
Cash flow statement
-56,554,000.00
Levered free cash flow (LFCF)
-14,909,125.00